Skip to content

Efficacy and Safety of white beans mixture on reducing body weight and body fat of overweight or obesity subjects: Clinical Trial

Efficacy and Safety of DKB-117 on reducing body weight and body fat of overweight or obesity subjects; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003749
Enrollment
100
Registered
2019-04-12
Start date
2018-12-27
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The tablet is effective of reducing the body fat and weight conducted by whitebeans and Avi mushroom. The test group takes four tablets a day, two tablets a day, before 30 minute

Sponsors

Dong Kook Pharm
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) person with BMI of 25kg/m2 or higher and less than 32kg/m2

Exclusion criteria

Exclusion criteria: 1) Those who are hospitalized, medication, and rehabilitated due to alcohol use and prevalence, heart disease, and central neuropathy through a medical history survey 2) people who has taken medications affect weight within the past month. 3) Patiens uncontrolled hypertension 4) Diabetic patients with fasting blood glucose greater than or equal to 126 mg / dl or those receiving oral hypoglycemic agents or insulin 5) Those who had a weight change of more than 10% within the last 3 months

Design outcomes

Primary

MeasureTime frame
Body fat percentage, fat mass by DEXA

Secondary

MeasureTime frame
weight;Waist circumference, Hip circumference;Fat content;Visceral fat area, subcutaneous fat area, total abdominal fat area, visceral / subcutaneous fat area non-fat amount;Total Cholesterol, HDL-Cholesterol, LDL-Cholesterol, Triglyceride;Adiponectine, leptin;hs-CRP;FBS, insulin

Countries

Korea, Republic of

Contacts

Public Contactro kyun

Hallym University Medical Center-Kangnam

rohyk@hallym.or.kr+82-2-829-5270

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026